Search

One of Turkey’s most established pharmaceutical companies, Santa Farma Pharmaceuticals, continues its strategic collaboration with Advanco.

Santa Farma Pharmaceuticals CEO Sami Kiresepi stated:

“At Santa Farma Pharmaceuticals, we operate with the vision of becoming a reference company in the healthcare sector by integrating local needs into global markets at world-class standards. Our partnership with Advanco enables us to make our processes more agile, expand and control our global scale more effectively, and ultimately enhance the value of the services we provide to our customers.”

With over 80 years of heritage in the pharmaceutical industry, Santa Farma Pharmaceuticals continues to deliver high-quality solutions that contribute to human health, while also investing in technological partnerships and initiatives that ensure global production standards.

Continuing its collaboration with Advanco, a leading global provider of serialization and traceability solutions for the pharmaceutical industry since 2015, Santa Farma leverages Advanco’s ARC system to enhance the reliability and efficiency of its manufacturing processes.

As Santa Farma transitions to a CDMO (Contract Development and Manufacturing Organization) model, the importance of its partnership with Advanco has grown even further, supporting the company’s new-generation manufacturing goals. With 127 products across 10 therapeutic areas, Santa Farma Pharmaceuticals continues to contribute to the global healthcare industry as one of Turkey’s leading pharmaceutical manufacturers, supported by significant investments in advanced technology.

CEO Sami Kiresepi: “Our new vision is to become a reference company in healthcare by connecting local needs with global standards.”

“At Santa Farma Pharmaceuticals, we continue to operate with the goal of becoming a reference company in the healthcare sector by integrating local needs into global markets at world-class standards. In a constantly evolving industry, we maintain a forward-looking and visionary approach to ensure sustainable and high-quality production. Reliability, transparency, and full compliance with regulations have always been our top priorities in pharmaceutical manufacturing,” said CEO Sami Kiresepi, who also shared his views on the partnership with Advanco:

“Our collaboration with Advanco, initiated in 2015, represents more than just a technical integration — it is a strategic partnership that helps shape the production standards of the future. Thanks to Advanco’s advanced traceability solutions, we are making our manufacturing processes more efficient while reinforcing our commitment to global compliance standards. This partnership also plays a critical role in Santa Farma’s transition to a CDMO structure, ensuring agility in our processes, expanding and controlling our digital network, and ultimately increasing the value we deliver to both local and global customers. I strongly believe that this collaboration will continue to grow stronger over the coming years and serve as a model for the industry.”